First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds

Rita Rubin

doi:10.1001/jama.2026.12326

July 2, 2026JAMA

First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study aims to evaluate the effectiveness and reliability of the first-ever approved blood test for Alzheimer disease.
Analyzed the performance of a newly approved plasma test for Alzheimer disease biomarkers.
Evaluated the accuracy in a real-world clinical setting.
Discussed implications of false-positive results on patient care.
The test showed a high rate of false-positive results, raising concerns about its overall reliability.
Implications suggest clinical caution is necessary when using this test in practice.

Implication

Reveals that the first plasma test for Alzheimer disease may produce numerous false-positive results, indicating potential challenges in clinical use.

Abstract

This Medical News article discusses a recent study in JAMA Neurology about the real-world use of the first approved plasma test for biomarkers of Alzheimer disease pathology.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rita Rubin (2026) studied this question.

synapsesocial.com/papers/6a48a57289561a0c2d78e2cd https://doi.org/10.1001/jama.2026.12326

View Full Paper

Ask AI

Bookmark

Share

First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds

Key Points

Implication

Abstract

Discussion

Cite This Study

First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading